Russian National BioService
The first biobank in Russia will be created in St. Petersburg
As reported today, on November 29, the correspondent of IA REGNUM, with reference to the project managers, within the framework of cooperation in St. Petersburg, the first Russian biobank "Russian National BioService" will be created on the basis of the Almazov Center.
Thus, the parties will join efforts to solve the most pressing problems facing Russian healthcare, as well as to create conditions for the development of personalized medicine. The partners' efforts will focus on several therapeutic areas, including cardiology and endocrinology, since cardiovascular and endocrine diseases are the main causes of death in the Russian Federation.
The Russian National BioService, which will start operating in the second half of 2013, will store and study the characteristics of biological samples for conducting biomedical research. The project also involves the creation of laboratories and the formation of a wide network of research organizations participating in the program throughout Russia. The Russian National BioService will become an infrastructure platform for the further development of personalized medicine. The activities of the biobank will fully comply with international ethical standards in the field of biobanking.
Within the framework of the Memorandum of Cooperation, each of the parties will contribute to the development of innovations in Russia by bringing its existing resources to the project: the Almazov Center – its scientific expertise and existing infrastructure in the field of biomedical research; the RVC Biofund – expertise in the field of venture investment, AstraZeneca – its long-term experience in the field of scientific research and development. AstraZeneca's role in the project will be to provide expert and consulting support to partners in the field of creating a biobank that meets international standards.
"The agreement that we are concluding will facilitate the conduct of research in key therapeutic areas for Russian healthcare, such as cardiology and endocrinology," notes the director of the Almazov Center, Academician of the Russian Academy of Medical Sciences, Doctor of Medical Sciences, Professor Evgeny Shlyakhto. "As one of the largest scientific and medical centers in Russia, we are pleased to join this partnership aimed at developing innovations for the benefit of Russian patients."
Portal "Eternal youth" http://vechnayamolodost.ru29.11.2012